Tonix Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $2,822 | $2,208 | $2,482 | $3,779 |
Gross Profit | 1,267 | -1,159 | 822 | 1,412 |
EBITDA | -15,554 | -17,392 | -20,379 | |
EBIT | -16,064 | -18,597 | -21,589 | |
Net Income | -14,213 | -78,776 | -14,939 | -27,322 |
Net Change In Cash | 2,822 | 2,208 | 2,482 | 3,779 |
Free Cash Flow | -18,810 | -9,919 | -17,683 | -22,778 |
Cash | 28,233 | 4,155 | 7,049 | 24,948 |
Basic Shares | 62,122 | 4,085 | 2,527 | 1,831 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $7,768 | $0 | $0 | $0 |
Gross Profit | 3,027 | -112,091 | -92,312 | -50,511 |
EBITDA | -114,089 | -110,838 | -92,262 | -50,484 |
EBIT | -118,380 | -112,091 | -92,312 | -50,511 |
Net Income | -116,658 | -115,004 | -92,212 | -50,388 |
Net Change In Cash | 7,768 | 0 | 0 | 0 |
Cost of Revenue | 101,623 | 65,975 | ||
Free Cash Flow | -109,898 | -146,200 | -110,864 | -57,130 |
Cash | 24,948 | 120,229 | 178,660 | 77,068 |
Basic Shares | 532 | 182 | 56 | 14 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.22 |
2024-06-30 | -$19.28 |
2024-03-31 | -$0.18 |
2023-12-31 | -$0.86 |
